Testing blood-flow measurements in ICU shock patients
Part of Infections clinical trials.
This trial studies how blood flow and organ “perfusion” look in ICU patients who are struggling with infection and low blood pressure. It may help doctors better measure and manage shock by comparing hemodynamic readings during standard treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a suspected or confirmed infection
- You need medicines through an IV (vasopressors) to keep blood pressure at a safe level (MAP 65 mmHg or higher)
- Your blood test shows lactate above 2 mmol/L
- You are receiving norepinephrine (a vasopressor) at more than 0.2 mcg/kg/min
- You can safely have an esophageal Doppler device and a urinary catheter if your clinicians recommend them
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how well the heart and blood vessels are working in people with septic shock. It helps doctors decide the best way to reduce blood pressure medication safely.
This trial tests whether different blood pressure medicines protect kidney function better in people with septic shock (a severe infection that causes low blood pressure). It compares norepinephrine (the standard treatment) with other options to see which is best for the kidneys.
This study uses a special ultrasound (Doppler) to check blood flow to your organs during septic shock. It helps doctors see if your body is getting enough blood and oxygen, which may guide better treatment.
This study looks at how a hormone system that controls blood pressure acts in people with septic shock (a severe infection causing low blood pressure). It compares patients with septic shock, sepsis without shock, cardiogenic shock, and healthy people to find differences that might lead to better treatments.
This trial looks at how the immune system changes after septic shock in adults in the ICU. It may help doctors better predict or manage complications by studying blood markers a few days after starting treatment.
This study looks at how the body responds to extra fluids in patients with severe infections (sepsis) who are on a breathing machine. It aims to understand how fluids affect blood flow and congestion to improve treatment.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.